This study investigates advanced/metastatic solid tumors. It focuses on participants who are relapsed, refractory, or intolerant to standard therapies.
The purpose of this study is to evaluate the safety and tolerability of an investigational medication. It looks at how the medication works in the body and its effects on tumors.
- Who can participate: Participants must be 18 years or older with advanced/metastatic solid tumors. They need a good performance status and adequate organ function.
- Study details: Participants will receive the investigational medication through IV infusion.
How understandable was the trial content above?
Hard to understand
Easy to understand